Pharmaceutical research in Argentina

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Pharmaceutical research in Argentina

Pharmaceutical research in Argentina – Cohortias the CRO of LATAM

Argentina has a long history of excellence in the field of pharmaceutical research. The country has a thriving pharmaceutical industry that is focused on developing innovative drugs and therapies to address some of the world’s most pressing healthcare challenges. Argentina is home to a range of world-class research institutions, universities, and companies that are dedicated to advancing knowledge in the field of healthcare and life sciences.

One of the key drivers of the growth of pharmaceutical research in Argentina is the country’s strong scientific infrastructure. Argentina has a rich tradition of scientific excellence, with a number of renowned research institutions, universities, and hospitals that are dedicated to advancing knowledge in the field of healthcare and life sciences.

These institutions have access to state-of-the-art facilities and equipment, as well as highly skilled scientists and researchers who are working on cutting-edge research projects.

Another important factor driving the growth of pharmaceutical research in Argentina is the country’s regulatory framework. Argentina has a rigorous regulatory system for drugs and healthcare products that is designed to ensure their safety, efficacy, and quality.

The National Administration of Drugs, Food, and Medical Technology (ANMAT) is responsible for overseeing the approval and regulation of drugs and other healthcare products, ensuring that they meet strict standards for safety and efficacy.

In addition to its strong scientific infrastructure and regulatory framework, Argentina’s pharmaceutical industry also benefits from the country’s diverse patient population. Argentina is home to more than 45 million people, with a wide range of healthcare needs.

The country has a high prevalence of diseases such as cancer, cardiovascular disease, and infectious diseases, which provides researchers and pharmaceutical companies with a unique opportunity to develop new drugs and therapies that can address these varied health challenges.

Pharmaceutical research in Argentina

Pharmaceutical research in Argentina

Pharmaceutical research in Argentina

Argentina has made significant contributions to the field of pharmaceutical research in recent years. The country has a strong tradition of developing innovative drugs and therapies, with a number of notable discoveries and breakthroughs in the field of healthcare. For example, in 2018, a team of Argentine researchers developed a new drug to treat tuberculosis that has shown promising results in clinical trials.

Argentina’s pharmaceutical industry also plays an important role in the global market, with the country exporting a wide range of drugs and healthcare products to countries around the world. The industry is a significant contributor to Argentina’s economy, providing jobs and generating revenue for the country.

Despite the many successes of the Argentine pharmaceutical industry, there are still some challenges that need to be addressed. One of the most significant of these is the need to improve access to healthcare for people living in remote and underprivileged areas.

Argentina has a large population living in poverty, and many of these individuals lack access to basic healthcare services. This can make it difficult for researchers to conduct clinical trials and develop new drugs that can meet the needs of these underserved populations.

Another challenge facing the Argentine pharmaceutical industry is the need to attract more investment and funding for research and development. While Argentina has made significant progress in the field of pharmaceutical research, the country still lags behind other major players in the industry, such as the United States and Japan, in terms of research funding and investment.

This makes it more difficult for Argentine researchers and companies to compete on a global scale and develop the innovative new drugs and therapies that are needed to address the world’s most pressing healthcare challenges.

In conclusion, pharmaceutical research in Argentina has a rich history of excellence and continues to be a major player in the global pharmaceutical industry. Argentina’s strong scientific infrastructure, rigorous regulatory framework, and access to a diverse patient population have all contributed to the country’s success in this critical field.

However, there is still work to be done to address the challenges facing the industry and ensure that Argentina continues to make important contributions to the development of new drugs and therapies for the benefit of people around the world.

Cohortias the CRO of LATAM

Source: World Courier

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Pharmaceutical research in Argentina

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Pharmaceutical research in Argentina

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Pharmaceutical research in Argentina

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Pharmaceutical research in Argentina

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Pharmaceutical research in Argentina

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Pharmaceutical research in Argentina

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Pharmaceutical research in Argentina

The Cohortias Team

Pharmaceutical research in Argentina

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Pharmaceutical research in Argentina

Network & Partnerships